MedTrace Logo

App-based Remote Blood Pressure Monitoring

NCT05595629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-02-19

Study results available
· View outcomes & findings →

Summary

Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to each individual text message. A bluetooth-enabled blood pressure cuff that synchs automatically a smartphone application that leverages Artificial Intelligence to provide tailored recommendations based on recorded blood pressure measurements--and can also provide on-demand education on hypertension--may be less costly way to provide similar support.

Conditions

  • Gestational Hypertension
  • Preeclampsia
  • Chronic Hypertension Complicating Pregnancy

Interventions

BEHAVIORAL

App-based remote blood pressure monitoring

Fully synched bluetooth-enabled remote blood pressure monitoring using a smartphone application. The digital health company, Twistle, has modified an existing postpartum hypertension pathway in their app according to our hospital's management algorithm.

BEHAVIORAL

text-message based remote blood pressure monitoring

Participants will receive automatic blood pressure cuffs and instructions as to how to upload their measurements to the Electronic Medical Record.

Sponsors & Collaborators

  • Women and Infants Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Adam Lewkowitz, MD, MPHS · Women and Infants Hospital of Rhode Island

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2023-06-30
Completion
2023-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05595629 on ClinicalTrials.gov